Publications by authors named "Nathan Starr"

Claim this Profile
O
Optimizing patient care and hospital operations through interhospital admission transfers: The load balancing protocol.
Harris L Carmichael, Adam Balls, Joseph Bledsoe, Michael Pirozzi, Nathan Starr

J Hosp Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermountain Healthcare's Hospital-Level Care at Home Program.
Nathan Starr, Harris L Carmichael, Samuel Thomas, Thea Sakata, Christine Lipson

Qual Manag Health Care· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial.
Samuel M Brown, Ithan Peltan, Naresh Kumar, Lindsay Leither, Brandon J Webb, Nathan Starr

Ann Am Thorac Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
Brandon J Webb, Ithan D Peltan, Paul Jensen, Daanish Hoda, Bradley Hunter, Nathan Starr

Lancet Rheumatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Wesley H Self, Matthew W Semler, Lindsay M Leither, Jonathan D Casey, Derek C Angus, Nathan Starr

JAMA· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial.
Samuel M Brown, Ithan D Peltan, Brandon Webb, Naresh Kumar, Nathan Starr

Ann Am Thorac Soc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Raymond S Turner, Michaeline L Hebron, Abigail Lawler, Elizabeth E Mundel, Nadia Yusuf, J Nathan Starr

Ann Neurol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Nathan J Starr

JAMA Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hospitalist Imperative: Standardizing Best Practice across Expanding Healthcare Networks.
Linda Venner, Nathan Starr, Raj Srivastava

J Hosp Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Nathan J Starr

Pharmacol Res Perspect· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis